| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | – | $4.81M | $3.08M | $3.33M | $2.27M |
| Operating Income | -$3.67M | -$4.70M | -$3.08M | -$3.23M | -$2.27M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $7.76M | $1.05M | $907.00K | $840.00K |
| Net Income | -$1.94M | -$7.91M | -$66.00K | -$3.23M | -$3.00M |
| EPS (basic) | -0.1500 | -0.6100 | -0.0050 | -0.2500 | -0.2300 |
| EPS (diluted) | -0.1500 | -0.6100 | -0.0050 | -0.2500 | -0.2300 |
| Shares (diluted) | $12.94M | $12.94M | $12.94M | $12.94M | – |